Cancel
Christopher J. Burns
Founder, President and Chief Executive Officer
@
Venatorx Pharmaceuticals
9.03fyy@0gdiq671.6k7
Sign up to see email
Known information
- Has 30 years of experience in the pharmaceutical industry.
- Held various corporate and R&D leadership positions at Protez/Novartis, ViroPharma, and Rhone-Poulenc Rorer (now Sanofi).
- Appeared as co-author or co-inventor on more than 60 patents and publications.
- Served as Principal Investigator on more than ten awarded U.S. National Institute of Health (NIH) grants.
- Received a B.S. in Chemistry from St. Joseph’s University.
- Received a Ph.D. in Organic Chemistry from the Massachusetts Institute of Technology (MIT) under Nobel-laureate Professor K. Barry Sharpless.
- Serves on the Board of Directors at Life Sciences Pennsylvania (LSPA) and the Antimicrobials Working Group (AWG).
- Serves on the Advisory Board for Life Science Cares Philadelphia.
- Was named Life Sciences Pennsylvania’s ‘CEO of the Year’ in 2019.
- Was named an Ernst and Young ‘Entrepreneur of the Year’ in 2019.
About Venatorx Pharmaceuticals
Venatorx Pharmaceuticals, founded in June 2010, focuses on developing novel anti-infectives to treat multi-drug-resistant bacterial and hard-to-treat viral infections. Their lead asset, cefepime-taniborbactam, has completed a Phase 3 study for complicated urinary tract infections and is under FDA review.
Report inaccurate information
